ChiCTR2100052245 版本V1.3 版本创建时间2022/04/23 13:49:50 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100052245 

最近更新日期:

Date of Last Refreshed on:

2022-04-23 13:43:49 

注册时间:

Date of Registration:

2021-10-23 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

厦门成人代谢综合征情况调查

Public title:

Prevalence of metabolic syndrome in Xiamen adults

注册题目简写:

English Acronym:

研究课题的正式科学名称:

厦门成人代谢综合征情况调查

Scientific title:

Prevalence of metabolic syndrome in Xiamen adults

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

丁珍贞 

研究负责人:

王翔飞 

Applicant:

Ding Zhenzhen 

Study leader:

Wang Xiangfei 

申请注册联系人电话:

Applicant telephone:

+86 13606067261

研究负责人电话:

Study leader's telephone:

+86 13681752880

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zzding63@163.com

研究负责人电子邮件:

Study leader's E-mail:

wang.xiangfei@zs-hospital.sh.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

福建省厦门市湖里区金湖路668号复旦大学附属中山医院厦门医院住院部8A病区

研究负责人通讯地址:

上海市徐汇区枫林路180号

Applicant address:

668 Jinhu Road, Huli District, Xiamen, Fujian

Study leader's address:

180 Fenglin Road, Xuhui District, Shanghai

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

复旦大学附属中山医院厦门医院

Applicant's institution:

Xiamen Hospital, Zhongshan Hospital Affiliated to Fudan University

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

B2021-021

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

复旦大学附属中山医院厦门医院伦理委员会

Name of the ethic committee:

Ethics Committee of Xiamen Branch, Zhongshan Hospital Affiliated to Fudan University

伦理委员会批准日期:

Date of approved by ethic committee:

1990-01-01 00:00:00

伦理委员会联系人:

顾建英

Contact Name of the ethic committee:

Gu Jianying

伦理委员会联系地址:

福建省厦门市湖里区金湖路668号

Contact Address of the ethic committee:

668 Jinhu Road, Huli District, Xiamen, Fujian

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

复旦大学附属中山医院

Primary sponsor:

Zhongshan Hospital Affiliated to Fudan University

研究实施负责(组长)单位地址:

上海市徐汇区枫林路180号

Primary sponsor's address:

180 Fenglin Road, Xuhui District, Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

福建

市(区县):

厦门

Country:

China

Province:

Fujian

City:

Xiamen

单位(医院):

复旦大学附属中山医院厦门医院

具体地址:

湖里区金湖路668号

Institution
hospital:

Xiamen Hospital, Zhongshan Hospital Affiliated to Fudan University

Address:

668 Jinhu Road, Huli District

经费或物资来源:

科室经费

Source(s) of funding:

Department funding

Target disease:

metabolic syndrome

Target disease code:

研究类型:

流行病学研究

Study type:

Epidemilogical research

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

分析厦门健康人群代谢综合征患病率、心脑血管疾病风险  

Objectives of Study:

Analysis of the prevalence of metabolic syndrome and the risk of cardiovascular and cerebrovascular diseases in healthy people in Xiamen

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

2020-07至2021-07于我院体检中心例行体检的年龄>18岁成年人的生物信息数据。

Inclusion criteria

From July 2020 to July 2021, the biological information data of adults who are older than 18 years of age undergoing routine physical examination in our hospital's physical examination center

排除标准:

Exclusion criteria:

none

研究实施时间:

Study execute time:

From 2021-12-01 00:00:00 To 2023-12-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-12-01 00:00:00 To 2022-12-01 00:00:00  

干预措施:

Interventions:

组别:

连续入组

样本量:

288

Group:

case series

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

福建 

市(区县):

福州 

Country:

China 

Province:

Fujian 

City:

Fuzhou 

单位(医院):

复旦大学附属中山医院厦门医院 

单位级别:

三级 

Institution
hospital:

Xiamen Hospital, Zhongshan Hospital Affiliated to Fudan University

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

身体质量指数

指标类型:

主要指标

Outcome:

Body mass index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血压

指标类型:

主要指标

Outcome:

Blood pressure

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血脂

指标类型:

主要指标

Outcome:

Blood lipids

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血糖

指标类型:

主要指标

Outcome:

Blood glucose

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

Null

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

none

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2021年12月1日起使用ResMan (www.medresman.org.cn)公开原始数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Use ResMan (www.medresman.org.cn) to disclose raw data from December 1st, 2021

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表、电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form (CRF), Electronic Data Capture (EDC)

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-10-23 23:34:35